We seem to be missing 8 million dollars here:
Revenue for first 9 months of 2016 = $34.24M
Q4 estimated revenue from Toprol = $22.5M (This is calculated as 90M for the year / 4 quarters) = 22.5M
Assuming no growth in Q4 (or seasonality (is there any?) offsetting the growth), that gives us:
34.2 (Revenue first 9 months)
+ 22.5 (Toprol XL Q4 Estimated)
———————————
= 56.75M + Q4 "other revenue"
The last quarter was just 13.5, so if other Q4 revenue is the same (assuming no growth), this puts us at $70 million for 2016, not 62 (at the high end). (That is, 56.75 + 13.5M = 70.25M)
Yet their top end guidance was 62M. Did they understate their 2016 net revenue guidance by 8M?
Where did the rest of the revenue go? Is Toprol seriously seasonal or something?
Help me out here....